Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
- PMID: 9626554
- DOI: 10.1210/edrv.19.3.0334
Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
Abstract
PRL is an anterior pituitary hormone that, along with GH and PLs, forms a family of hormones that probably resulted from the duplication of an ancestral gene. The PRLR is also a member of a larger family, known as the cytokine class-1 receptor superfamily, which currently has more than 20 different members. PRLRs or binding sites are widely distributed throughout the body. In fact, it is difficult to find a tissue that does not express any PRLR mRNA or protein. In agreement with this wide distribution of receptors is the fact that now more than 300 separate actions of PRL have been reported in various vertebrates, including effects on water and salt balance, growth and development, endocrinology and metabolism, brain and behavior, reproduction, and immune regulation and protection. Clearly, a large proportion of these actions are directly or indirectly associated with the process of reproduction, including many behavioral effects. PRL is also becoming well known as an important regulator of immune function. A number of disease states, including the growth of different forms of cancer as well as various autoimmune diseases, appear to be related to an overproduction of PRL, which may act in an endocrine, autocrine, or paracrine manner, or via an increased sensitivity to the hormone. The first step in the mechanism of action of PRL is the binding to a cell surface receptor. The ligand binds in a two-step process in which site 1 on PRL binds to one receptor molecule, after which a second receptor molecule binds to site 2 on the hormone, forming a homodimer consisting of one molecule of PRL and two molecules of receptor. The PRLR contains no intrinsic tyrosine kinase cytoplasmic domain but associates with a cytoplasmic tyrosine kinase, JAK2. Dimerization of the receptor induces tyrosine phosphorylation and activation of the JAK kinase followed by phosphorylation of the receptor. Other receptor-associated kinases of the Src family have also been shown to be activated by PRL. One major pathway of signaling involves phosphorylation of cytoplasmic State proteins, which themselves dimerize and translocate to nucleus and bind to specific promoter elements on PRL-responsive genes. In addition, the Ras/Raf/MAP kinase pathway is also activated by PRL and may be involved in the proliferative effects of the hormone. Finally, a number of other potential mediators have been identified, including IRS-1, PI-3 kinase, SHP-2, PLC gamma, PKC, and intracellular Ca2+. The technique of gene targeting in mice has been used to develop the first experimental model in which the effect of the complete absence of any lactogen or PRL-mediated effects can be studied. Heterozygous (+/-) females show almost complete failure to lactate after the first, but not subsequent, pregnancies. Homozygous (-/-) females are infertile due to multiple reproductive abnormalities, including ovulation of premeiotic oocytes, reduced fertilization of oocytes, reduced preimplantation oocyte development, lack of embryo implantation, and the absence of pseudopregnancy. Twenty per cent of the homozygous males showed delayed fertility. Other phenotypes, including effects on the immune system and bone, are currently being examined. It is clear that there are multiple actions associated with PRL. It will be important to correlate known effects with local production of PRL to differentiate classic endocrine from autocrine/paracrine effects. The fact that extrapituitary PRL can, under some circumstances, compensate for pituitary PRL raises the interesting possibility that there may be effects of PRL other than those originally observed in hypophysectomized rats. The PRLR knockout mouse model should be an interesting system by which to look for effects activated only by PRL or other lactogenic hormones. On the other hand, many of the effects reported in this review may be shared with other hormones, cytokines, or growth factors and thus will be more difficult to study. (ABSTRACT TRUNCATED)
Similar articles
-
Prolactin: a hormone at the crossroads of neuroimmunoendocrinology.Ann N Y Acad Sci. 1998 May 1;840:498-509. doi: 10.1111/j.1749-6632.1998.tb09588.x. Ann N Y Acad Sci. 1998. PMID: 9629276 Review.
-
From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models.Genet Anal. 1999 Nov;15(3-5):189-201. doi: 10.1016/s1050-3862(99)00025-x. Genet Anal. 1999. PMID: 10596761 Review.
-
Physician Education: The Erythropoietin Receptor and Signal Transduction.Oncologist. 1996;1(5):337-339. Oncologist. 1996. PMID: 10388012
-
The prolactin/growth hormone receptor family.Endocr Rev. 1991 Aug;12(3):235-51. doi: 10.1210/edrv-12-3-235. Endocr Rev. 1991. PMID: 1935820 Review.
-
Prolactin signaling influences the timing mechanism of the hair follicle: analysis of hair growth cycles in prolactin receptor knockout mice.Endocrinology. 2001 Jun;142(6):2533-9. doi: 10.1210/endo.142.6.8179. Endocrinology. 2001. PMID: 11356702
Cited by
-
Effect of prolactin on normal and keratoconus human corneal stromal fibroblasts in vitro.PLoS One. 2021 Apr 1;16(4):e0249344. doi: 10.1371/journal.pone.0249344. eCollection 2021. PLoS One. 2021. PMID: 33793669 Free PMC article.
-
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Oncotarget. 2017 Jan 10;8(2):3724-3745. doi: 10.18632/oncotarget.12554. Oncotarget. 2017. PMID: 27741508 Free PMC article. Review.
-
Serotonin competence of mouse beta cells during pregnancy.Diabetologia. 2016 Jul;59(7):1356-1363. doi: 10.1007/s00125-016-3951-2. Epub 2016 Apr 7. Diabetologia. 2016. PMID: 27056372 Review.
-
The effect of prolactin on immune cell subsets involved in SLE pathogenesis.Front Immunol. 2022 Oct 28;13:1016427. doi: 10.3389/fimmu.2022.1016427. eCollection 2022. Front Immunol. 2022. PMID: 36389803 Free PMC article. Review.
-
Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among nonsmoking women seeking in vitro fertilization.Environ Toxicol Pharmacol. 2012 Nov;34(3):761-7. doi: 10.1016/j.etap.2012.09.010. Epub 2012 Sep 23. Environ Toxicol Pharmacol. 2012. PMID: 23046534 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous